BONUSCAP-ZERTIFIKAT - BIONTECH ADR Share Price

Certificat

DE000HD4AL70

Real-time BOERSE MUENCHEN 01:16:00 04/06/2024 am IST
137 EUR +1.14% Intraday chart for BONUSCAP-ZERTIFIKAT - BIONTECH ADR
1 month+22.37%
Date Price Change
04/24/04 137 +1.14%
31/24/31 135.4 -0.87%
30/24/30 136.6 +10.03%
29/24/29 124.2 -0.32%
28/24/28 124.6 -6.50%

Real-time BOERSE MUENCHEN

Last update June 04, 2024 at 01:16 am IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying BIONTECH SE
IssuerLogo Issuer UniCredit UniCredit
WKN HD4AL7
ISINDE000HD4AL70
Date issued 02/04/2024
Strike 160 $
Maturity 20/12/2024 (200 Days)
Parity 1 : 1
Emission price 116
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 140.3
Lowest since issue 100.4
Spread 0.04
Spread %0.03%

Company Profile

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Sector
-
More about the company

Ratings for BioNTech SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: BioNTech SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
92.76 EUR
Average target price
103.1 EUR
Spread / Average Target
+11.14%
Consensus